Federal Official Gazette
DECISION OF MARCH 5, 2026
The Board of Directors of the National Supplementary Health Agency, in the exercise of its legal and regimental powers, unanimously approved, at its 4th extraordinary meeting of 2026, held on March 3, 2026, the following exceptional and temporary enforcement measures, owing to the state of public calamity in the region of Juiz de Fora/MG, Matias Barbosa/MG and Ubá/MG resulting from strong and intense rainfall, on the following terms:
Measures of a temporary nature and, without prejudice, subject to review at any time by the Board of Directors: (i) Measure 1: Granting of 10 (ten) additional business days for responding to the NIP. The measure will be automatically revoked 30 calendar days counted from Feb 24, 2026. It is emphasized that this measure does not apply to each and every claim, but only to those in which the system status indicates “Aguardando reposta da Operadora” (awaiting response from the operator) in the period from the declaration of the state of public calamity, that is, February 24, 2026; (ii) Measure 2: Extension of the deadline for voluntary and effective redress, pursuant to art. 11, §1°, item I of RN No. 483/2022, by 10 more business days, covering the complaint claims that are in the status “Aguardando reposta da Operadora” (awaiting response from the operator) on February 24, 2026. The measure will be automatically revoked 30 calendar days counted from Feb 24, 2026; (iii) Measure 3: Suspension of the deadlines of sanctioning administrative proceedings in the period from February 24, 2026 to March 26, 2026, with the deadline count resuming from March 27, 2026, it being incumbent on the operators to prove the exceptional situation by attaching the public calamity decree; and (IV): Measure 4: Differentiated treatment also applies to complaint claims concerning compliance with Normative Resolution No. 623/2024 regarding facts occurring from February 24, 2026, it being incumbent on the operators to prove the exceptional situation by attaching the public calamity decree.
The proposed application is restricted to health plan operators headquartered in Juiz de Fora/MG, Matias Barbosa/MG or Ubá/MG.
ANS news
January: medical care plans have 53 million beneficiaries
The National Supplementary Health Agency (ANS) releases this Thursday, Mar 5, 2026, the data on health plan beneficiaries for January: 52,996,625 in medical care plans and 35,487,403 in exclusively dental plans. These and other data can be consulted in the Sala de Situação, a research tool on information about the health plan sector available on the regulator’s portal.
The figures show that, in medical-hospital plans, January saw a reduction of 91,359 beneficiaries compared with the previous month. Compared with the same month in 2025, the sector gained 1,028,065 beneficiaries.
Exclusively dental plans also recorded a decline from one month to the next, totaling 22,755 beneficiaries compared with December. But from January 2025 to January 2026, 1,128,819 beneficiaries joined the segment.
5th Extraordinary Meeting of the Board of Directors of 2026
The National Supplementary Health Agency (ANS) holds this Friday (Mar 6, 2026), starting at 11:30 a.m., the 5th Extraordinary Meeting of the Board of Directors (DICOL) of 2026.
The agenda addresses the proposal to update the List of Health Procedures and Events (Rol).
Analyses of the 48th technical meeting of Cosaúde
The session began with the analysis of the contributions to Public Consultation No. 163, on the technology Lebrikizumab, for the treatment of adult patients with severe atopic dermatitis who have failed, are intolerant to, or have a contraindication to cyclosporine.
Next, participants discussed the contributions to Public Consultation No. 166, concerning left atrial appendage exclusion technology, for the treatment of patients with atrial fibrillation (characterized by irregular heartbeats) or at high risk of thromboembolic events (such as stroke), undergoing open heart surgery for other indications.
Finally, there was a preliminary discussion on the technology Olaparib, for the treatment of adult patients with metastatic castration-resistant prostate cancer with BRCA 1 or 2 gene mutations, whose disease has progressed after prior treatment with a new hormonal agent.
Open public consultations
- CP 168. Subject: CP opened for the submission of criticism and suggestions regarding the proposed amendment of Normative Resolutions No. 516 and 521, of 2022. Deadline: Feb 23, 2026 to Apr 9, 2026.
Scheduled public hearings
There are no scheduled public hearings.
Open public calls for input
There is no open public call for input.
Open public calls
No updates.
Other news
STJ sets parameters for requiring health plans to cover insulin pumps
Source: jota.info · read the full article
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.